Also, in terms of tuberculosis preventive treatment—an intervention mainly provided to people with HIV that helps to cut the risk of Mycobacterium tuberculosis infection progressing to active disease—the report unveiled that there was a 21% decrease in the number of people receiving this treatment globally during 2019–20 (from 3·6 million to 2·8 million), showing a reversal of a positive trend, which was noted during 2015–19 (increasing from 1 million to 3·6 million in that period). “We are heavily worried about how the COVID-19 pandemic has disrupted TB care and prevention in countries with a high TB burden”, said Lucica Ditiu (Stop TB Partnership, Geneva, Switzerland).
1
—
—